Home
>
National Drug Code (NDC)
>
Bisoprolol Fumarate and Hydrochlorothiazide
Bisoprolol Fumarate and Hydrochlorothiazide - 0185-0701-01 - (Bisoprolol Fumarate and Hydrochlorothiazide)
Drug Information of Bisoprolol Fumarate and Hydrochlorothiazide
| Product NDC: | 0185-0701 |
| Proprietary Name: | Bisoprolol Fumarate and Hydrochlorothiazide |
| Non Proprietary Name: | Bisoprolol Fumarate and Hydrochlorothiazide |
| Active Ingredient(s): | 2.5; 6.25 mg/1; mg/1 & nbsp; Bisoprolol Fumarate and Hydrochlorothiazide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Bisoprolol Fumarate and Hydrochlorothiazide
| Product NDC: | 0185-0701 |
| Labeler Name: | Eon Labs, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075579 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20000925 |
Package Information of Bisoprolol Fumarate and Hydrochlorothiazide
| Package NDC: | 0185-0701-01 |
| Package Description: | 100 TABLET, COATED in 1 BOTTLE (0185-0701-01) |
NDC Information of Bisoprolol Fumarate and Hydrochlorothiazide
| NDC Code | 0185-0701-01 |
| Proprietary Name | Bisoprolol Fumarate and Hydrochlorothiazide |
| Package Description | 100 TABLET, COATED in 1 BOTTLE (0185-0701-01) |
| Product NDC | 0185-0701 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Bisoprolol Fumarate and Hydrochlorothiazide |
| Dosage Form Name | TABLET, COATED |
| Route Name | ORAL |
| Start Marketing Date | 20000925 |
| Marketing Category Name | ANDA |
| Labeler Name | Eon Labs, Inc. |
| Substance Name | BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
| Strength Number | 2.5; 6.25 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
